Zorglim M 2mg/500mg Tablet (10) Benefits & Uses
Zorglim M 2mg/500mg Tablet (10) is used to treat the following -
Main Benefits
- Diabetes (Read More - 10 Home Remedies for Diabetes)
Other Benefits
- Diabetes Type 2
Zorglim M 2mg/500mg Tablet (10) Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Zorglim M 2mg/500mg Tablet (10) Related Warnings
-
Is the use of Zorglim M 2mg/500mg Tablet (10) safe for pregnant women?
No research has been done to ascertain the safety of Zorglim M in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Unknown -
Is the use of Zorglim M 2mg/500mg Tablet (10) safe during breastfeeding?
Zorglim M is completely safe for breastfeeding women.
Safe -
What is the effect of Zorglim M 2mg/500mg Tablet (10) on the Kidneys?
Zorglim M can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
Moderate -
What is the effect of Zorglim M 2mg/500mg Tablet (10) on the Liver?
There may be an adverse effect on the liver after taking Zorglim M. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
Moderate -
What is the effect of Zorglim M 2mg/500mg Tablet (10) on the Heart?
Very few cases of side effects of Zorglim M on the heart have been reported.
Mild
Zorglim M 2mg/500mg Tablet (10) Contraindications
If you are suffering from any of the following diseases, you should not take Zorglim M 2mg/500mg Tablet (10) unless your doctor advises you to do so -
- Heart Disease
- Kidney Disease
- Liver Disease
- Anemia
Frequently asked Questions about Zorglim M 2mg/500mg Tablet (10)
-
Is this Zorglim M 2mg/500mg Tablet (10) habit forming or addictive?
Forming a habit of Zorglim M 2mg/500mg Tablet (10) has not been reported.
No -
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Zorglim M 2mg/500mg Tablet (10). So it is best to avoid driving.
Dangerous -
Is it safe?
Yes, but take Zorglim M 2mg/500mg Tablet (10) only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
There is no benefit of taking Zorglim M 2mg/500mg Tablet (10) for mental disorders.
No
Zorglim M 2mg/500mg Tablet (10) Interactions with Food and Alcohol
-
Interaction between Food and Zorglim M 2mg/500mg Tablet (10)
There is no information on the effects of taking Zorglim M 2mg/500mg Tablet (10) with food, because this topic has not been scientifically researched yet.
Unknown -
Interaction between Alcohol and Zorglim M 2mg/500mg Tablet (10)
Information about the interaction of Zorglim M 2mg/500mg Tablet (10) and alcohol is not currently available because this topic has not been researched yet.
Unknown
See all substitutes for Zorglim M
- Azulix 2 MF Tablet PR - ₹199
- Gluconorm G 0.5 Tablet PR - ₹87
- Glimestar M 3 Forte Tablet (10) - ₹111
- Glimestar M 2 Forte Tablet (30) - ₹252
- Glimestar M 1 Forte Tablet (30) - ₹219
- Gluconorm G2 Forte Tablet PR - ₹198
- Glimestar M 2/1000 Mg SR Tablet (10) - ₹79
- Gluconorm G1 Tablet PR - ₹152
- Glimy M 2 Tablet PR - ₹206
- Azulix 3 MF Tablet PR - ₹73
- Glimestar M 1/500 Mg SR Tablet (10) - ₹58
- Azulix 2 MF Forte Tablet PR - ₹231
- Azulix 1 MF Tablet PR - ₹127
- Azulix 4 MF Tablet PR - ₹129
- Azulix 4 MF Forte Tablet PR - ₹166
- Gluconorm G3 Forte Tablet - ₹199
- Gluconorm G1 Forte Tablet PR - ₹169
- Gluconorm G2 Tablet PR - ₹229
- Azulix 1 MF Forte Tablet PR - ₹165
- Glimestar M 4 Forte Tablet PR (10) - ₹116
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826